- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05219084
Hip Denervation and Intra-articular Hydration in Damaged Hip in Axial Spondyloarthritis Patients
Background: The hip joint is frequently affected in axial spondyloarthritis (SpA) of adults with destructive effects in untreated patients. About 35% of axial SpA patients had either unilateral or bilateral hip arthritis. Destruction is more common with early-onset, active disease, or enthesitis.
Objectives: The aim of this study is to evaluate the effect of hip denervation (HD) and intra-articular hydration (IAH) on pain, function score, hip mobility scores in a cohort of axial SpA patients with grade 3 and 4 hip BASRI scores.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Fase 3
Kontakter og lokationer
Studiesteder
-
-
-
Sohag, Egypten, 82749
- Ahmed Elsaman
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- age 18 or more
- Axial; SpA fulfilled ASA criteria
- BASRI score grade 3 or 4 for one hip at least
Exclusion Criteria:
- patients younger than 18
- Axial; SpA with normal hip or hip involvement less than 3 on BASRI score
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Placebo komparator: placebo group
5ml of normal; saline-injected subcutaneously
|
Normal; saline was injected subcutaneously
|
Aktiv komparator: Hip denervatiopn
Hip denervation with lidocaine 2% to each genicular branch, 2ml at each point
|
Lidocaine 2% 2ml was injected into each genicular nerve
|
Aktiv komparator: Inra-articular hydration
10 ml of normal saline injected inside the hip under ultrasound guidance
|
10 ml; of normal; saline were injected inside the hip joint
|
Aktiv komparator: compined group
hip denervation and intra-articular hydration were conducted together in this group
|
hip denervation and intra-articular hydration were conducted together
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Change in visual analogue scale
Tidsramme: Baseline , after 4 weeks and after 12 weeks
|
0 means no pain, 100 means the highest degree of pain
|
Baseline , after 4 weeks and after 12 weeks
|
Change in Harris functional hip score
Tidsramme: Baseline, after 4 weeks and after 12 weeks
|
Pain receives 44 points, function 47 points, range of motion 5 points, and deformity 4 points. Function is subdivided into activities of daily living (14 points) and gait (33 points). The higher the HHS, the less dysfunction. A total score of <70 is considered a poor result; 70-80 is considered fair, 80-90 is good, and 90-100 is an excellent result |
Baseline, after 4 weeks and after 12 weeks
|
Change in range of motion of the hip
Tidsramme: Baseline, after 4 weeks and after 12 weeks
|
hip flexion, extension , internal; rotation , external; rotation , abduction , and adduction all were recopreded
|
Baseline, after 4 weeks and after 12 weeks
|
Change in semiquantitative tenderness score
Tidsramme: Baseline, after 4 weeks and after 12 weeks
|
a score from 0-3, 90 means no tenderness and 3 means maximum tenderness
|
Baseline, after 4 weeks and after 12 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- SC 250
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Control group
-
Duke UniversityNational Institute of Nursing Research (NINR); National Institutes of Health...Aktiv, ikke rekrutterendeKroniske nyresygdomme | Diabetes mellitus, type 1 | Systemisk lupus erythematosus | Inflammatoriske tarmsygdomme | Cystisk fibrose | Seglcellesygdom | Stamcelletransplantation | Barnekræft | OrgantransplantationForenede Stater
-
Bright Cloud International CorpNational Cancer Institute (NCI); Rutgers, The State University of New JerseyRekrutteringKognitiv svækkelse, mildForenede Stater
-
The University of Texas Health Science Center,...RekrutteringDynaCleft®-effekter på blødt væv og på livskvalitet for spædbørn med ufuldstændig ensidig læbespalteLæbe- og ganespalteForenede Stater
-
National Institute of Diabetes and Digestive and...Detroit Department of HealthAfsluttet
-
Federico II UniversityAfsluttetSund og rask | Overvægt og fedmeItalien
-
University of California, San FranciscoMount Zion Health Fund; Pritzker Family Foundation; Mental Insight FoundationAfsluttetDepression, UnipolarForenede Stater
-
Johns Hopkins Bloomberg School of Public HealthNative American Research Centers for Health (NARCH)AfsluttetDepressive symptomer | StofbrugForenede Stater
-
University of ParmaAfsluttetMotorisk aktivitet | Hemiplegisk cerebral pareseItalien
-
University of MichiganAfsluttetForældreskabForenede Stater
-
University of ArkansasTrukket tilbageMeibomisk kirtel dysfunktionForenede Stater